Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone for adult parapneumonic pleural effusion
ACTRN12618000947202Phase 3Completed
- Sponsor
- Institute for Respiratory Health
- Start
- Jun 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexamethasone in parapneumonic effusion, sponsored by Institute for Respiratory Health. Primary endpoint: Time to clinical stability. Started Jun 2018; status: completed.
02
Drugs
dexamethasone
03
Conditions
parapneumonic effusion
Beyond the preview
Go deeper on ACTRN12618000947202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618000947202.